Emma Knight
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emma Knight has a total of 125 co-authors. Here are the top co-authors by number of shared publications:
- Adrian D. Manning
Fenner School of Environment and Society, The Australian National University, Acton, ACT 2601, Australia
6 shared publications David B. Lindenmayer
The Fenner School of Environment and Society The Australian National University Canberra ACT 0200 Australia
6 shared publications- Joern Fischer
Leuphana University Lüneburg
6 shared publications - David B. Lindenmayer
Fenner School of Environment and Society The Australian National University Canberra Australian Capital Territory Australia
5 shared publications - Karen Ikin
The Australian National University
4 shared publications - Sam Banks
AResearch Institute for the Environment and Livelihoods, Charles Darwin University, Darwin, NT, Australia
3 shared publications
Latest Publications
- Open Access
- 5 December 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 592
Reduced social support perpetuates disadvantage across the lifespan for Australian women
People who experience disadvantage in childhood—broadly defined as hardship across various social, economic, and health domains—tend to continu
- 5 December 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25 (1) , 592
Open AccessReduced social support perpetuates disadvantage across the lifespan for Australian women
People who experience disadvantage in childhood—broadly defined as hardship across various social, economic, and health domains—tend to continu
- 1 November 2022
- Published by Emerald Publishing in Proceedings of the Institution of Civil Engineers - Management, Procurement and Law
- Vol. 175 (4) , 177-186
Construction Law Quarterly
- 1 November 2022
- Published by Emerald Publishing in Proceedings of the Institution of Civil Engineers - Management, Procurement and Law
- Vol. 175 (4) , 177-186
Construction Law Quarterly
- 1 May 2020
- Published by Elsevier in The American Journal of Pathology
- Vol. 190 (5) , 977-993
Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing
- 1 May 2020
- Published by Elsevier in The American Journal of Pathology
- Vol. 190 (5) , 977-993
Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing
- 22 February 2018
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 33 (3) , 599-607
Limited uptake of ulcerative colitis “treat‐to‐target” recommendations in real‐world practice
Background and Aims: A “treat‐to‐target” approach has been proposed for ulcerative colitis (UC), with a target of combined clinical and endoscopic remission. The aim of the study was to evaluate the extent to which proposed targets are achieved in real‐world care, along with clinician perceptions and potential challenges.Methods: A multicentre, retrospective, cross‐sectional review of patients with UC attending outpatient services in South Australia was conducted. Clinical and objective assessment of disease activity (endoscopy, histology, and/or biomarkers) was recorded. A survey evaluated gastroenterologists' perceptions of treat to target in UC. Statistical analysis included logistic regression and Fisher's exact tests.Results: Of 246 patients with UC, 61% were in clinical remission (normal bowel habit and no rectal bleeding), 35% in clinical and endoscopic remission (Mayo endoscopic sub‐score ≤ 1), and 16% in concordant clinical, endoscopic, and histological (Truelove and Richards' Index) remission. Rather than disease‐related factors (extent/activity), clinician‐related factors dominated outcome. Hospital location and the choice of therapy predicted combined clinical and endoscopic remission (OR 3.6, 95% CI 1.6–8.7, P < 0.001; OR 3.3, 95% CI 1.1–12.5, P = 0.04, respectively). Clinicians used C‐reactive protein more often than endoscopy as a biomarker for disease activity (75% vs 47%, P < 0.001). In the survey, 45/61 gastroenterologists responded, with significant disparity between clinician estimates of targets achieved in practice and real‐world data (P < 0.001 for clinical and endoscopic remission).Conclusions: Most patients with UC do not achieve composite clinical and endoscopic remission in “real‐world” practice. Clinician uptake of proposed treat‐to‐target guidelines is a challenge to their implementation.
- 22 February 2018
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 33 (3) , 599-607
Limited uptake of ulcerative colitis “treat‐to‐target” recommendations in real‐world practice
Background and Aims: A “treat‐to‐target” approach has been proposed for ulcerative colitis (UC), with a target of combined clinical and endoscopic remission. The aim of the study was to evaluate the extent to which proposed targets are achieved in real‐world care, along with clinician perceptions and potential challenges.Methods: A multicentre, retrospective, cross‐sectional review of patients with UC attending outpatient services in South Australia was conducted. Clinical and objective assessment of disease activity (endoscopy, histology, and/or biomarkers) was recorded. A survey evaluated gastroenterologists' perceptions of treat to target in UC. Statistical analysis included logistic regression and Fisher's exact tests.Results: Of 246 patients with UC, 61% were in clinical remission (normal bowel habit and no rectal bleeding), 35% in clinical and endoscopic remission (Mayo endoscopic sub‐score ≤ 1), and 16% in concordant clinical, endoscopic, and histological (Truelove and Richards' Index) remission. Rather than disease‐related factors (extent/activity), clinician‐related factors dominated outcome. Hospital location and the choice of therapy predicted combined clinical and endoscopic remission (OR 3.6, 95% CI 1.6–8.7, P < 0.001; OR 3.3, 95% CI 1.1–12.5, P = 0.04, respectively). Clinicians used C‐reactive protein more often than endoscopy as a biomarker for disease activity (75% vs 47%, P < 0.001). In the survey, 45/61 gastroenterologists responded, with significant disparity between clinician estimates of targets achieved in practice and real‐world data (P < 0.001 for clinical and endoscopic remission).Conclusions: Most patients with UC do not achieve composite clinical and endoscopic remission in “real‐world” practice. Clinician uptake of proposed treat‐to‐target guidelines is a challenge to their implementation.
- 1 January 2018
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 21 (1) , 84-88
Use of a tibial accelerometer to measure ground reaction force in running: A reliability and validity comparison with force plates
- 1 January 2018
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 21 (1) , 84-88
Use of a tibial accelerometer to measure ground reaction force in running: A reliability and validity comparison with force plates
- 18 May 2016
- Published by Taylor & Francis in The Journal of Spinal Cord Medicine
- Vol. 39 (6) , 671-678
Physiological and perceptual effects of precooling in wheelchair basketball athletes
Objective: To investigate the physiological and perceptual effects of three precooling strategies during pre-exercise rest in athletes with a spinal cord injury (SCI). Design: Randomized, counterbalanced. Participants were precooled, then rested for 60 minutes (22.7 ± 0.2°C, 64.2 ± 2.6%RH). Setting: National Wheelchair Basketball Training Centre, Australia. Participants: Sixteen wheelchair basketball athletes with a SCI. Interventions: Participants were precooled through; 1) 10 minutes of 15.8°C cold water immersion (CWI), 2) ingestion of 6.8 g/kg−1 of slushie (S) from sports drink; 3) ingestion of 6.8 g/kg−1 of slushie with application of iced towels to the legs, torso and back/arms (ST); or 4) ingestion of 6.8 g/kg−1 of room temperature (22.3°C) sports drink (CON). Outcome measures: Core temperature (Tgi), skin temperature (Tsk), heart rate (HR), and thermal and gastrointestinal comfort. Results: Following CWI, a significant reduction in Tgi was observed compared to CON, with a greatest reduction of 1.58°C occurring 40 minutes post-cooling (95% CI [1.07, 2.10]). A significant reduction in Tgi following ST compared to CON was also observed at 20 minutes (0.56°C; [0.03, 1.09]) and 30 minutes (0.56°C; [0.04, 1.09]) post-cooling. Additionally, a significant interaction between impairment level and time was observed for Tgi and HR, demonstrating athletes with a higher level of impairment experienced a greater reduction in HR and significant decrease in rate of decline in Tgi, compared to lesser impaired athletes. Conclusion: CWI and ST can effectively lower body temperature in athletes with a SCI, and may assist in tolerating warm conditions.
- 18 May 2016
- Published by Taylor & Francis in The Journal of Spinal Cord Medicine
- Vol. 39 (6) , 671-678
Physiological and perceptual effects of precooling in wheelchair basketball athletes
Objective: To investigate the physiological and perceptual effects of three precooling strategies during pre-exercise rest in athletes with a spinal cord injury (SCI). Design: Randomized, counterbalanced. Participants were precooled, then rested for 60 minutes (22.7 ± 0.2°C, 64.2 ± 2.6%RH). Setting: National Wheelchair Basketball Training Centre, Australia. Participants: Sixteen wheelchair basketball athletes with a SCI. Interventions: Participants were precooled through; 1) 10 minutes of 15.8°C cold water immersion (CWI), 2) ingestion of 6.8 g/kg−1 of slushie (S) from sports drink; 3) ingestion of 6.8 g/kg−1 of slushie with application of iced towels to the legs, torso and back/arms (ST); or 4) ingestion of 6.8 g/kg−1 of room temperature (22.3°C) sports drink (CON). Outcome measures: Core temperature (Tgi), skin temperature (Tsk), heart rate (HR), and thermal and gastrointestinal comfort. Results: Following CWI, a significant reduction in Tgi was observed compared to CON, with a greatest reduction of 1.58°C occurring 40 minutes post-cooling (95% CI [1.07, 2.10]). A significant reduction in Tgi following ST compared to CON was also observed at 20 minutes (0.56°C; [0.03, 1.09]) and 30 minutes (0.56°C; [0.04, 1.09]) post-cooling. Additionally, a significant interaction between impairment level and time was observed for Tgi and HR, demonstrating athletes with a higher level of impairment experienced a greater reduction in HR and significant decrease in rate of decline in Tgi, compared to lesser impaired athletes. Conclusion: CWI and ST can effectively lower body temperature in athletes with a SCI, and may assist in tolerating warm conditions.
- 1 February 2016
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 19 (2) , 103-108
Normative MRI, ultrasound and muscle functional MRI findings in the forearms of asymptomatic elite rowers
- 1 February 2016
- Published by Elsevier in Journal of Science and Medicine in Sport
- Vol. 19 (2) , 103-108
Normative MRI, ultrasound and muscle functional MRI findings in the forearms of asymptomatic elite rowers
- 19 May 2015
- Published by Wiley in Drug Testing and Analysis
- Vol. 8 (2) , 228-234
Within‐subject haemoglobin variation in elite athletes: a longitudinal investigation of 13 887 haemoglobin concentration readings
The Athlete Biological Passport (ABP) estimates individualized reference ranges for key blood markers, such as haemoglobin concentration ([Hb]), using predetermined population mean, between‐ and within‐subject variances. Here, we aim to reassess previously published estimates for within‐subject [Hb] variance and determine whether sex‐, analyzer‐, sport‐, or season‐specific values are required. Our reference population contains 7723 male (mean ± SD, 22.3 ± 4.6 years of age) and 6164 female (21.6 ± 4.3) athlete observations from 49 sports. [Hb] was calculated using one of three cytometers; Bayer‐H3 (1997–1999, n = 4554), ADVIA‐120 (1999–2010, n = 8636) and Sysmex XT‐2000i (2010–2012, n = 697). The final model was a linear mixed model for [Hb] with analyzer (H3, ADVIA, Sysmex), sex (male, female), sport (power‐endurance, endurance, skill, team, disabled and non‐athletes), season (summer, winter), and the interaction between sex and sport as fixed effects and athlete as a random effect. The model included an exponential correlation structure to allow for within‐subject autocorrelation, and allowed different within‐subject variances for each sport. Within‐subject [Hb] variance (g2/L2) was significantly less for power endurance (35.09, 95% CI 33.50 to 36.76), disabled (25.82, 95% CI 21.71 to 35.28) and non‐athletes (34.30, 95% CI 28.53 to 35.87) than for endurance (40.35, 95% CI 39.62 to 47.22) and team sports (38.70, 95% CI 37.68 to 39.76) athletes. No new evidence was found to justify adjusting the current within‐subject [Hb] variance estimate. Copyright © 2015 John Wiley & Sons, Ltd.
- 19 May 2015
- Published by Wiley in Drug Testing and Analysis
- Vol. 8 (2) , 228-234
Within‐subject haemoglobin variation in elite athletes: a longitudinal investigation of 13 887 haemoglobin concentration readings
The Athlete Biological Passport (ABP) estimates individualized reference ranges for key blood markers, such as haemoglobin concentration ([Hb]), using predetermined population mean, between‐ and within‐subject variances. Here, we aim to reassess previously published estimates for within‐subject [Hb] variance and determine whether sex‐, analyzer‐, sport‐, or season‐specific values are required. Our reference population contains 7723 male (mean ± SD, 22.3 ± 4.6 years of age) and 6164 female (21.6 ± 4.3) athlete observations from 49 sports. [Hb] was calculated using one of three cytometers; Bayer‐H3 (1997–1999, n = 4554), ADVIA‐120 (1999–2010, n = 8636) and Sysmex XT‐2000i (2010–2012, n = 697). The final model was a linear mixed model for [Hb] with analyzer (H3, ADVIA, Sysmex), sex (male, female), sport (power‐endurance, endurance, skill, team, disabled and non‐athletes), season (summer, winter), and the interaction between sex and sport as fixed effects and athlete as a random effect. The model included an exponential correlation structure to allow for within‐subject autocorrelation, and allowed different within‐subject variances for each sport. Within‐subject [Hb] variance (g2/L2) was significantly less for power endurance (35.09, 95% CI 33.50 to 36.76), disabled (25.82, 95% CI 21.71 to 35.28) and non‐athletes (34.30, 95% CI 28.53 to 35.87) than for endurance (40.35, 95% CI 39.62 to 47.22) and team sports (38.70, 95% CI 37.68 to 39.76) athletes. No new evidence was found to justify adjusting the current within‐subject [Hb] variance estimate. Copyright © 2015 John Wiley & Sons, Ltd.
- Open Access
- 13 May 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0123302
The Effects of a Calcium-Rich Pre-Exercise Meal on Biomarkers of Calcium Homeostasis in Competitive Female Cyclists: A Randomised Crossover Trial
Cycling is recognised as a sport in which there is a high incidence of poor bone health. Sweat calcium losses may contribute to this. To examine whether a calcium-rich pre-exercise meal attenuates exercise-induced perturbations of bone calcium homeostasis caused by maintenance of sweat calcium losses. Using a randomized, counterbalanced crossover design, 32 well-trained female cyclists completed two 90 min cycling trials separated by 1 day. Exercise trials were preceded 2 hours by either a calcium-rich (1352 ± 53 mg calcium) dairy based meal (CAL) or a control meal (CON; 46 ± 7 mg calcium). Blood was sampled pre-trial; pre-exercise; and immediately, 40 min, 100 min and 190 min post-exercise. Blood was analysed for ionized calcium and biomarkers of bone resorption (Cross Linked C-Telopeptide of Type I Collagen (CTX-I), Cross Linked C-Telopeptide of Type II Collagen (CTX-II), Parathyroid Hormone (PTH), and bone formation (Procollagen I N-Terminal Propeptide (PINP)) using the established enzyme-linked immunosorbent assay technique. PTH and CTX-I increased from pre-exercise to post-exercise in both conditions but was attenuated in CAL (p < 0.001). PTH was 1.55 [1.20, 2.01] times lower in CAL immediately post-exercise and 1.45 [1.12, 1.88] times lower at 40 min post-exercise. CTX-I was 1.40 [1.15, 1.70] times lower in CAL at immediately post-exercise, 1.30 [1.07, 1.57] times lower at 40 min post-exercise and 1.22 [1.00, 1.48] times lower at 190 min post-exercise (p < 0.05). There was no significant interaction between pre-exercise meal condition and time point for CTX-II (p = 0.732) or PINP (p = 0.819). This study showed that a calcium-rich pre-exercise breakfast meal containing ~1350 mg of calcium consumed ~90 min before a prolonged and high intensity bout of stationary cycling attenuates the exercise induced rise in markers of bone resorption – PTH and CTX-I. Australian New Zealand Clinical Trials Registry ACTRN12614000675628
- 13 May 2015
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0123302
Open AccessThe Effects of a Calcium-Rich Pre-Exercise Meal on Biomarkers of Calcium Homeostasis in Competitive Female Cyclists: A Randomised Crossover Trial
Cycling is recognised as a sport in which there is a high incidence of poor bone health. Sweat calcium losses may contribute to this. To examine whether a calcium-rich pre-exercise meal attenuates exercise-induced perturbations of bone calcium homeostasis caused by maintenance of sweat calcium losses. Using a randomized, counterbalanced crossover design, 32 well-trained female cyclists completed two 90 min cycling trials separated by 1 day. Exercise trials were preceded 2 hours by either a calcium-rich (1352 ± 53 mg calcium) dairy based meal (CAL) or a control meal (CON; 46 ± 7 mg calcium). Blood was sampled pre-trial; pre-exercise; and immediately, 40 min, 100 min and 190 min post-exercise. Blood was analysed for ionized calcium and biomarkers of bone resorption (Cross Linked C-Telopeptide of Type I Collagen (CTX-I), Cross Linked C-Telopeptide of Type II Collagen (CTX-II), Parathyroid Hormone (PTH), and bone formation (Procollagen I N-Terminal Propeptide (PINP)) using the established enzyme-linked immunosorbent assay technique. PTH and CTX-I increased from pre-exercise to post-exercise in both conditions but was attenuated in CAL (p < 0.001). PTH was 1.55 [1.20, 2.01] times lower in CAL immediately post-exercise and 1.45 [1.12, 1.88] times lower at 40 min post-exercise. CTX-I was 1.40 [1.15, 1.70] times lower in CAL at immediately post-exercise, 1.30 [1.07, 1.57] times lower at 40 min post-exercise and 1.22 [1.00, 1.48] times lower at 190 min post-exercise (p < 0.05). There was no significant interaction between pre-exercise meal condition and time point for CTX-II (p = 0.732) or PINP (p = 0.819). This study showed that a calcium-rich pre-exercise breakfast meal containing ~1350 mg of calcium consumed ~90 min before a prolonged and high intensity bout of stationary cycling attenuates the exercise induced rise in markers of bone resorption – PTH and CTX-I. Australian New Zealand Clinical Trials Registry ACTRN12614000675628
- 1 April 2015
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 47 (4) , 886
Response
- 1 April 2015
- Published by Wolters Kluwer Health in Medicine & Science in Sports & Exercise
- Vol. 47 (4) , 886
Response